SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Sintx Technologies, Inc. (SINT) (CIK 0001269026) (SINT) — Jun 30, 2016

Sintx Technologies, Inc. (SINT) (CIK 0001269026)
Date: June 30, 2016 · CIK: 0001269026 · Accession: 0001493152-16-011194

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-211520

Date
June 30, 2016
Author
Chief
Form
CORRESP
Company
Sintx Technologies, Inc. (SINT) (CIK 0001269026)

Letter

Amedica Corporation

West 2100 South

Salt Lake City, Utah 84119

June 30, 2016

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

F. Street, N.E.

Washington, D.C. 20549

Attention: Caleb French

Re: Amedica Corporation (the “Company”)

Registration Statement on Form S-1

File No. 333-211520

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement on Form S-1 (File No. 333-211520), as amended (the “Registration Statement”), be accelerated so that it will be declared effective at 5:00 p.m., Washington, D.C. time on July 1, 2016, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Dorsey & Whitney LLP, by calling David Marx at (801) 933-7363.

The Company hereby acknowledges that:

● should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

● the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

● the Company may not assert comments of the Commission or the staff and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Very
truly yours,
Amedica
Corporation

Show Raw Text
CORRESP
1
filename1.htm

Amedica
Corporation

1885
West 2100 South

Salt
Lake City, Utah 84119

June
30, 2016

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

100
F. Street, N.E.

Washington,
D.C. 20549

Attention:     Caleb
French

Re:
Amedica Corporation (the “Company”)

Registration
Statement on Form S-1

File
No. 333-211520

Ladies
and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective
date for the Registration Statement on Form S-1 (File No. 333-211520), as amended (the “Registration Statement”),
be accelerated so that it will be declared effective at 5:00 p.m., Washington, D.C. time on July 1, 2016, or as soon thereafter
as is practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel,
Dorsey & Whitney LLP, by calling David Marx at (801) 933-7363.

The
Company hereby acknowledges that:

    ●
    should
    the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority,
    declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

    ●
    the
    action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not
    relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

    ●
    the
    Company may not assert comments of the Commission or the staff and the declaration of effectiveness as a defense in any proceeding
    initiated by the Commission or any person under the federal securities laws of the United States.

    Very
    truly yours,

    Amedica
    Corporation

    By:
    /s/
    Ty Lombardi

    Name:
    Ty
    Lombardi

    Title:
    Chief
    Financial Officer